bioithas

Advice and dissemination

For Bioithas, disseminating knowledge to specialists and users is a fundamental objective that will allow us to continue advancing thanks to knowing the concerns that exist in the population.

Ask for information

Our experience in research in the field of human microbiota and probiotics, both in the public and private sectors, has allowed us to act, especially the founder and Scientific Director of Bioithas, Dr. Vicente Navarro, as scientific advisors of several companies and pharmaceutical and food sector companies for the development of their new products and R&D projects.

All of this has given us great experience in the field of scientific dissemination in our field of research, giving talks and presentations at many national and international conferences and conferences, research centers, and private hospitals and clinics.

Our accreditations

Los datos de carácter personal que consten en la consulta serán tratados por BIOITHAS, S.L. e incorporados a la actividad de tratamiento CONTACTOS, cuya finalidad es atender tus solicitudes, peticiones o consultas recibidas desde la web, mediante correo electrónico o telefónico. Dar respuesta a tu solicitud y hacer un seguimiento posterior.

La legitimación del tratamiento es tu consentimiento. Tus datos no serán cedidos a terceros. Tienes derecho a acceder, rectificar y suprimir tus datos, así como otros derechos como se explica en nuestra política de privacidad: https://www.adelopd.com/privacidad/bioithas-sl

Si quieres más información

Rellena con tus datos y nos pondremos en contacto contigo.

It may interest you

Scientific articles

Below, we detail the scientific articles published and led by our scientific director Vicente Navarro López, in several of the most important indexed journals in the world.

QUALIFICATION PUBLICATION
Descriptive Study of Gut Microbiota in Infected and Colonized Subjects by Clostridiodes difficile Microorganisms, 2021; 9(8):1727. doi: 10.3390/microorganisms9081727.
Probiotics in the Therapeutic Arsenal of Dermatologists Microorganisms, 2021; 9(7):1513. doi: 10.3390/microorganisms9071513.
Study of the Vaginal Microbiota in Healthy Women of Reproductive Age Microorganisms, 2021; 9(5):1069. doi: 10.3390/microorganisms9051069.
Changes in Gut Microbiota Correlates with Response to Treatment with Probiotics in Patients with Atopic Dermatitis. A Post Hoc Analysis of a Clinical Trial.
Microorganisms, 2021; 9(4): 854, doi: 10.3390/microorganisms9040854.
Efficacy and Safety of Oral Administration of a Mixture of Probiotic Strains in Patients with Psoriasis: a Randomized Clinical Trial.
Acta Dermato-Venereologica, 2019; 99(12): 1078-1084, doi:10.2340/00015555-3305.
Gut microbial composition in patients with psoriasis.
Scientific Reports, 2018; 8(1): 3812, doi: 10.1038/s41598-018-22125-y.

Others

Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients With Moderate Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatology, 2018; 154(1): 37–43, doi: 10.1001/jamadermatol. 2017.3647.

Identification of Bacterial DNA in the Peripheral Blood of Patients With Active Psoriasis. JAMA Dermatology, 2015; 151(6): 670-1, doi: 10.1001/jamadermatol. 2014.5585.

Reducing test request for anti-thyroglobulin and anti-thyroid peroxidase antibodies: trends before and after interventions based on rejection rules and profile management. Medical Biochemia. 28 – 3, pp. https://doi.org/10.11613/BM.2018.030709. Croatian Society of Medical Biochemistry and Laboratory Medicine, 01/10/2018

Publications in Congresses

Intestinal microbiota as a new prognostic factor for relapsing-remitting multiple sclerosis. “LXXII Annual Meeting of the Spanish Society of Neurology”, 11/23/2020 – 12/03/2020.

Salivary microbiota as a proposed diagnostic biomarker in head and neck cancer. “XI Workshop of the Spanish Society of Microbiota, Probiotics and Prebiotics (SEMiPyP)”. Granada, 02/07/2020 – 02/09/2020.

A new target for the treatment of acne vulgaris. Pilot research study. AEDV 2019, 47th National Congress of Dermatology and Venereology. Barcelona, ​​06/05/2019 – 06/08/2019.

Randomized double-blind placebo-controlled clinical trial to evaluate the safety and effect of a probiotic mixture on the PASI index in patients with moderate psoriasis. AEDV 2018, 46th National Congress of Dermatology and Venereology. Palma de Mallorca, 09/0/2018 – 05/12/2018.

Alpha diversity study in patients with Clostridium difficile infection and asymptomatic carriers. X Workshop of the Spanish Society of Probiotics and Preb'iotics (SEPyP). Las Palmas de Gran Canaria, 02/06/2019 – 02/08/2019 Spanish Society of Probiotics and Prebiotics (SEPyP).

Other Academic Awards

Research Patronage Award 2019. Awarded by the Social Council of the University of Alicante.

National Research Award, Pfizer Chair in Psoriasis, Autonomous University of Madrid 2015. Bacterial Translocation in a case series of patients with psoriasis.

Best Research Project by the Spanish Society of Dermatology during 2015. Bacterial Translocation in a case series of patients with psoriasis.

Access to the best national clinical research work with the use of probiotics. Atopic dermatitis. A randomized clinical trial. National Congress of the Spanish Society of Probiotics and Prebiotics. SEPYP Workshop 2017

National Award for the best clinical research work with oral communication. Psoriasis. A randomized clinical trial. National Congress of the Spanish Society of Probiotics and Prebiotics, Workshop SEPYP 2018

Award for the best Oral Communication of clinical uses. Multiple sclerosis and microbiota. Original Investigation. Spanish Society of Probiotics and Prebiotics, SEPYP 2019 Workshop.

National Award: access to the best work in poster format. Differences in the intestinal microbiota of asymptomatic and symptomatic carrier patients with clostridium difficile infection. Study of a cohort of patients.